ESC & iPSC News Volume 16.02 | Jan 20 2021

    0
    84







    2021-20-1 | ESC 16.02


    ESC & iPSC News by STEMCELL Technologies
    Vol. 16.02 – 20 January, 2021
    TOP STORY

    Single Cell Transcriptomic Analysis of Human Pluripotent Stem Cell Chondrogenesis

    Scientists combined bulk RNA sequencing, single cell RNA sequencing, and bioinformatic analyses, including weighted gene co-expression analysis, to investigate the gene regulatory networks regulating human iPSC differentiation under chondrogenic conditions.
    [Nature Communications]

    Full Article

    Survey Report: Where Is Pluripotent Stem Cell Research Now?
    PUBLICATIONSRanked by the impact factor of the journal

    Cellular and Molecular Landscape of Mammalian Sinoatrial Node Revealed by Single-Cell RNA Sequencing

    Deficiency of Vsnl1 not only reduced the beating rate of human iPSC-derived cardiomyocytes but also the heart rate of mice. Weighted gene co-expression network analysis unveiled the core gene regulation network governing the function of the sinoatrial node in mice.
    [Nature Communications]

    Full Article

    OCT4 Induces Embryonic Pluripotency via STAT3 Signaling and Metabolic Mechanisms

    Scientists used single-cell whole-genome transcriptional profiling and protein quantification to investigate the role of OCT4 in establishing pluripotency in the murine embryo.
    [Proceedings of the National Academy of Sciences of the United States of America]

    Full Article

    PIAS1 Modulates Striatal Transcription, DNA Damage Repair, and SUMOylation with Relevance to Huntington’s Disease

    Investigators evaluated the mechanistic contributions of protein inhibitor of activated STAT-1 (PIAS1) in Huntington’s disease (HD) mice and HD patient-derived iPSCs and found a link between PIAS1 and DNA damage repair pathways.
    [Proceedings of the National Academy of Sciences of the United States of America]

    Full Article

    Greater Epithelial Ridge Cells Are the Principal Organoid-Forming Progenitors of the Mouse Cochlea

    Scientists purified different cochlear cell types from neonatal mice, validated the composition of the different groups with single-cell RNA sequencing, and assessed the various groups’ potential to grow into inner ear organoids.
    [Cell Reports]

    Full ArticleGraphical Abstract

    PU.1 Drives Specification of Pluripotent Stem Cell-Derived Endothelial Cells to LSEC-Like Cells

    Researchers present a computational workflow that could identify transcription factors that were crucial for modulating pathways involved in cell lineage specification.
    [Cell Death & Disease]

    Full Article

    Aberrant Development of Pancreatic Beta Cells Derived from Human iPSCs with FOXA2 Deficiency

    Investigators generated iPSCs from a patient with FOXA2 haploinsufficiency followed by beta-cell differentiation to understand the role of FOXA2 during pancreatic beta-cell development.
    [Cell Death & Disease]

    Full Article

    Vulnerability to Shear Stress Caused by Altered Peri-Endothelial Matrix Is a Key Feature of Moyamoya Disease

    Glycosaminoglycans of endothelial cells derived from Moyamoya disease (MMD) and control iPSCs were analyzed. A computational fluid dynamics model was also developed to show the distribution of values for vascular wall shear stress in the predisposing region of MMD.
    [Scientific Reports]

    Full Article

    Direct Reprogramming of Epithelial Cell Rests of Malassez into Mesenchymal-Like Cells by Epigenetic Agents

    Epithelial cell rests of malassez was cultured in ESC medium with 1 µM of 5-Azacytidine (5Aza), or 2 mM of valproic acid (Vpa), or a combination of 5Aza and Vpa. The cells stimulated with both 5Aza and Vpa were named as progenitor-dedifferentiated into stem-like cells.
    [Scientific Reports]

    Full Article

    New mTeSRâ„¢ Plus hPSC Maintenance Medium
    REVIEWS

    Generation and Manipulation of Human iPSC-Derived Platelets

    The authors focus on the current status of the development, application and manipulation of iPSC-derived platelet-like particles, which has been leading the field of regenerative medicine using iPSC-derived blood cells and has reached the first-in-human clinical trial.
    [Cellular and Molecular Life Sciences]

    Full Article

    Pluripotent Stem Cells for Disease Modeling and Drug Discovery in Niemann-Pick Type C1

    Scientists present a review focusing on studies that have used iPSCs for disease modeling and drug discovery in Niemann-Pick disease Type C1 (NPC1) and draw a comparison to commonly used NPC1 models.
    [International Journal of Molecular Sciences]

    Full Article

    INDUSTRY AND POLICY NEWS

    RheinCell Therapeutics Achieves Milestone GMP Certification to Manufacture Cord Blood-Derived iPSCs for Safe and Compliant Cell Therapies

    RheinCell Therapeutics GmbH announced it has received Good Manufacturing Practice certification and Manufacturing Authorization. This marks a landmark achievement for RheinCell, which is now among a select few iPSCs manufacturers to have received the critical certification.
    [Lifescience Newswire]

    Press Release

    FEATURED EVENT

    Virtual PSC Maintenance and Cell Quality Training Course – February

    February 8 – 10, 2021
    Virtual

    > See All Events

    JOB OPPORTUNITIES

    Scientific Communities & Communications Specialist

    STEMCELL Technologies, Inc. – Burnaby, British Columbia, Canada

    Postdoctoral Researcher – Neuroimmunology

    University of Luxembourg – Luxembourg City, Luxembourg

    PhD Studentship – Bioengineering and Biotechnologies

    Queen Mary University of London – London, England, United Kingdom

    Research Technician – Stem Cell and Genome Editing

    The University of British Columbia – Vancouver, British Columbia, Canada

    Senior Manager – FACS-Based Characterization

    Fondazione Human Technopole – Milan, Italy

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    ESC & iPSC News Twitter